Form 8-K - Current report:
SEC Accession No. 0001558370-25-008814
Filing Date
2025-06-24
Accepted
2025-06-24 08:00:14
Documents
12
Period of Report
2025-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20250620x8k.htm   iXBRL 8-K 39650
  Complete submission text file 0001558370-25-008814.txt   148699

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpth-20250620.xsd EX-101.SCH 3289
3 EX-101.LAB bpth-20250620_lab.xml EX-101.LAB 15300
4 EX-101.PRE bpth-20250620_pre.xml EX-101.PRE 9744
14 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20250620x8k_htm.xml XML 4690
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 251066705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)